Gwinnett Medical Center

The Gwinnett Medical Center is accredited by the Commission on Cancer of the American College of Surgeons as a Community Hospital Comprehensive Cancer Program. The Gwinnet Medical Center is a member of the Atlanta Regional Community Clinical Oncology Program (ARCCOP), a program initiated by the National Cancer Institute (NCI) to provide community hospitals access to a wide range of clinical research studies. The Gwinnett Medical Center Breast health Center is accredited by the American College of Surgeons’ National Accreditation Program for Breast Centers (NAPBC). Gwinnett Medical Center also accredited by the American College of Radiology (ACR). The Gwinnett Medical Center has two locations (Duluth and Lawrenceville). In an effort to satisfy a mission of providing the most advanced, comprehensive cancer care, they offer a full range of cancer fighting services, including: screening and early detection programs, diagnostic imaging, interventional radiology, surgical procedures, radiation oncology services, medical oncology services; support groups; healthy lifestyle programs and rehabilitation services.

Treatment Sites in Georgia

Clinical Trials in Georgia

A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B Cell or T Cell Non-Hodgkin Lymphoma (NHL)
Cancer Type: Non-Hodgkin Lymphoma
Study Coordinator: Elle Coe - 678-312-3848


A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Cancer Type: Lung Cancer
Study Coordinator: Elle Coe - 678-312-3848


A Phase III Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).
Cancer Type: Colon/Rectal Cancer
Study Coordinator: Elle Coe - 678-312-3848


A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Cancer Type: Breast Cancer
Study Coordinator: Jan Miller - 678-312-3825


Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer
Study Coordinator: Elle Coe - 678-312-3848


Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) – A Randomized Phase III Study of Nivolumab after Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers
Cancer Type: Lung Cancer
Study Coordinator: Elle Coe - 678-312-3848


Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Cancer Type: Lung Cancer
Study Coordinator: Elle Coe - 678-312-3848


Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Cancer Type: Breast Cancer
Study Coordinator: Shaneka Douglas - 678-312-3834